Form D · Other Technology
GENE NETWORK SCIENCES, INC.
Cambridge, MA · CIK 0001136056
Offering snapshot reported Nov 30, 2010 · SEC filing
- Reported sold
- $450K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2010 | Initial | $450,000 | No comparison | 1 | SEC filing |
| Aug 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-151160
Source: Form D, filed Nov 30, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Biloski | Director |
| J. Weston Cashman | Director |
| Michael Gilman | Director |
| Colin Hill | Director, Executive |
| Iya Khalil | Executive |
| Duncan Mcfarland | Director |
| Thomas Neyarapally | Executive |
| Thomas Paul | Director |
| F. Raymond Salemme | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
58 Charles Street
Cambridge, MA, 02141
Cambridge, MA, 02141